top of page
CYTORA LOGO
Contact-us-banner

CONTACT US

Small-orange-line

Email

Divider-orange-line-Team-smalle

Social Media

  • LinkedIn
Circle-bg
Cytora bottom logo

Cytora’s patented platform technology is based on the discovery of a novel and unique stem cell population in the human oral mucosa (hOMSC), the origin of which is the embryonic nervous system. hOMSC are endowed with properties of neural crest, neural and mesenchymal stem cells. Cytora’s products are allogeneic, off-the-shelf, easily scalable, with a very competitive cost of goods (COG). The products were found to be safe and effective in early phase clinical trials in two indications: Diabetic Foot Ulcers (DFU) and Multiple System Atrophy (MSA).

Our products have high potential for treating complicated multifactorial diseases such as chronic and neurodegenerative diseases, incurable wounds and autoimmune diseases.

MENU

Dividing blue line

CONTACT US

© 2022 Cytora. All rights reserved.

bottom of page